BWX Technologies, Inc. filings document the regulatory record of a NYSE-listed nuclear manufacturing and engineering company serving government and commercial markets. Its disclosures cover operating and financial results, segment performance, backlog-related business activity, risk factors, and material events connected to nuclear propulsion, nuclear fuel, and commercial nuclear operations.
BWXT’s SEC filings also address governance and capital structure. Recent records include proxy materials and annual meeting voting results, board and executive officer matters, registered common stock information, material agreements, and convertible senior notes due 2030 with related subsidiary guarantees.
BWX Technologies, Inc. launched a private offering of $500 million aggregate principal amount of senior unsecured notes due 2034, guaranteed by present and future wholly owned subsidiaries that are obligors under its existing credit agreement. It also commenced cash tender offers for any and all outstanding 4.125% senior notes due 2028 and 2029; the stated outstanding principal amount is $400 million for each series.
BWXT intends to use the new notes’ net proceeds, together with cash on hand, to purchase notes tendered and accepted, address the related indentures and pay associated costs. The tender offers are subject to conditions including successful completion of the new notes offering and sufficient proceeds plus cash, in BWXT’s reasonable judgment. The new notes offering is not conditioned on completion of the tender offers.
The offers expire at 5:00 p.m. New York City time on November 10, 2026, unless extended or earlier terminated; settlement is expected November 13, 2026. Consideration is based on the applicable U.S. Treasury yield plus a 50-basis-point fixed spread. Proposed indenture amendments require consents representing at least a majority of each series’ outstanding principal and become operative only after accepted notes are paid for.
BWX Technologies, Inc. amended its credit agreement, extending the maturity of its $1.25 billion senior secured revolving credit facility by one year to November 10, 2031.
The minimum interest coverage ratio no longer applies if no default or event of default exists and the company obtains investment grade corporate or corporate family ratings, with a stable outlook or better, from at least two designated rating agencies. The pricing grid is based on the lower of the existing leverage-ratio grid and a grid tied to the applicable corporate or corporate family rating. Other credit agreement terms remain in full force and effect.
BWX Technologies, Inc. (BWXT) reported third-quarter 2026 revenue of $953.0 million, up 10% from a year earlier, and net income of $102.0 million, up 24%. Diluted GAAP EPS was $1.11, up 25%; adjusted EBITDA was $179.7 million, up 19%; and free cash flow was $150.5 million, up 59%. Commercial Operations revenue rose 25% to $314.2 million, while Government Operations revenue rose 4% to $639.1 million.
BWXT reaffirmed 2026 revenue guidance of approximately $3.8 billion and narrowed non-GAAP EPS guidance to $4.72-$4.77 and free cash flow guidance to $350-$360 million. Adjusted EBITDA guidance is approximately $667 million, at the midpoint of the prior range. Its preliminary 2027 outlook calls for high-single-digit revenue growth and high-single-digit to low-double-digit growth in adjusted EBITDA and non-GAAP EPS. BWXT also said its advanced nuclear reactor technology was selected for the U.S. Army's Janus Program at Fort Campbell and Prodigy Clean Energy's transportable nuclear power plant project in Canada.
BWX Technologies, Inc. (BWXT) reported third-quarter 2026 revenue of $953.0 million, up 10.0% from $866.3 million, and net income attributable to BWXT of $101.7 million, versus $82.1 million. Diluted earnings per share were $1.11, compared with $0.89. For the first nine months, revenue was $2,714.8 million versus $2,312.6 million, and operating cash flow was $451.7 million versus $352.9 million.
Government Operations quarterly revenue rose 3.6% to $639.1 million; Commercial Operations revenue rose 25.2% to $314.2 million, while its operating margin was 8.4%, compared with 9.5%. BWXT completed its Precision Components Group acquisition on July 1, 2026. On July 31, it agreed to sell its medical business to Nordic Capital in a transaction valued at up to $800 million. The sale is subject to customary regulatory approvals and expected to be completed in 2026 or the first quarter of 2027; BWXT will retain a minority interest and provide specialized isotope and radiochemical expertise.
Backlog was $8,556.2 million as of September 30, 2026, including $1,970.9 million of unfunded U.S. Government contract backlog. BWXT expects approximately 46% of backlog-related revenue to be recognized by the end of 2027, with the remainder thereafter.
BWX Technologies, Inc. (symbol: BWXT) is the issuer of record for a Form 4 filing submitted to the SEC. Burbach Gerhard F reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. (BWXT) director Gerhard F. Burbach received an award of 23.19 Dividend Equivalent Rights (DERs) on September 4, 2026, tied to previously granted restricted stock units. After this grant, he holds 801.11 DERs directly. Each DER represents a contingent right to receive one share of BWXT common stock, delivered proportionately with the related RSUs.
BWX Technologies, Inc. (symbol: BWXT) is the issuer of record for a Form 4 filing submitted to the SEC. JASKA JAMES M reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. (BWXT) reported that director James M. Jaska received an automatic accrual of 28.29 Dividend Equivalent Rights (DERs) on September 4, 2026 in respect of previously granted deferred restricted stock units. Following this accrual, he holds 1,138.68 DERs directly, each representing a contingent right to receive one share of BWXT common stock, delivered proportionately as the related RSUs are paid.
BWX Technologies, Inc. (BWXT) director Daniel L. Jablonsky acquired 1.52 Dividend Equivalent Rights (DERs) on September 4, 2026, tied to previously granted deferred restricted stock units. After this award, he holds 2.97 DERs, each representing a contingent right to receive one share of BWXT common stock as the related RSUs are delivered.
BWX Technologies, Inc. (BWXT) director Kenneth J. Krieg reported an acquisition of 36.14 Dividend Equivalent Rights on September 4, 2026, tied to deferred restricted stock units. Following this grant, he holds 1,486.95 Dividend Equivalent Rights, each representing a contingent right to receive one share of BWXT common stock.
BWX Technologies, Inc. (symbol: BWXT) is the issuer of record for a Form 4 filing submitted to the SEC. Melvin Leland D reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. (BWXT) reported that director Melvin Leland D received a grant of 15.43 Dividend Equivalent Rights (DERs) on September 4, 2026, tied to previously granted restricted stock units (RSUs). Following this grant, he holds 243.83 DERs directly.
Each RSU and corresponding DER represents a contingent right to receive one share of BWXT common stock. The director has elected to defer receipt of the RSU shares, and the DERs will be delivered to him proportionately with the related RSUs. No Rule 10b5-1 trading plan is reported for this transaction.
BWX Technologies, Inc. (symbol: BWXT) is the issuer of record for a Form 4 filing submitted to the SEC. PIASECKI NICOLE WEYERHAEUSER reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. (BWXT) director Nicole Weyerhaeuser Piasecki reported an automatic grant of 7.8 Dividend Equivalent Rights on September 4, 2026, tied to previously granted restricted stock units for which she elected deferral. Each right corresponds to one share of BWXT common stock, bringing her reported dividend-equivalent balance to 61.21 rights, to be delivered proportionately with the related RSUs.